Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Bacteriostatic Water - IV Administration Warning
The selective inhibitor compound 27 (IPN60090), which is currently in a first-in-class clinical trial, focuses on optimising physicochemical and pharmacokinetic properties, with a strong in vivo target engagement capability, and should strongly inhibit GLS in humans [152, 153]
10.3390/nu12092832 50
Proc Natl Acad Sci 104(12):49494954 Cao Y, Yan Z, Zhou T, Wang G (2017) SIRT1 regulates cognitive performance and ability of learning and memory in diabetic and nondiabetic models
Room temperature storage Avoid it entirely
Step-by-Step Injection Guide Subcutaneous injection represents the most common administration route for DSIP
US$ 23.99
US$ 26.15
US$ 25.32
